CAMERA, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 945
EU - Europa 881
AS - Asia 681
SA - Sud America 124
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 2
AN - Antartide 1
Totale 2.717
Nazione #
US - Stati Uniti d'America 884
RU - Federazione Russa 427
SG - Singapore 293
IT - Italia 203
BR - Brasile 98
VN - Vietnam 94
CN - Cina 76
HK - Hong Kong 69
GB - Regno Unito 51
DE - Germania 41
BD - Bangladesh 40
FI - Finlandia 34
CA - Canada 28
TR - Turchia 21
FR - Francia 20
LT - Lituania 18
IN - India 17
NL - Olanda 15
AT - Austria 12
IE - Irlanda 11
JP - Giappone 11
KR - Corea 11
PL - Polonia 11
MX - Messico 10
BJ - Benin 9
ES - Italia 9
SE - Svezia 9
AR - Argentina 7
CO - Colombia 7
ID - Indonesia 7
IL - Israele 7
IQ - Iraq 7
TG - Togo 7
ZA - Sudafrica 7
GT - Guatemala 6
PH - Filippine 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
JM - Giamaica 4
NG - Nigeria 4
CL - Cile 3
EG - Egitto 3
HN - Honduras 3
MA - Marocco 3
AU - Australia 2
BE - Belgio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
IR - Iran 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
PK - Pakistan 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SX - ???statistics.table.value.countryCode.SX??? 1
TC - Turks e Caicos 1
TH - Thailandia 1
TN - Tunisia 1
UG - Uganda 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.679
Città #
Ashburn 167
Moscow 161
Singapore 143
San Jose 140
Dallas 76
Hong Kong 68
Verona 48
Council Bluffs 42
Ho Chi Minh City 34
New York 26
Los Angeles 25
Beijing 24
Santa Clara 24
Munich 19
Hanoi 17
Helsinki 16
Istanbul 16
Milan 16
Vilnius 16
São Paulo 15
London 14
Phoenix 12
Montreal 11
Orem 10
Rome 10
The Dalles 10
Amsterdam 9
Buffalo 9
Chicago 9
Cotonou 9
Tokyo 9
Turku 9
Chandler 8
Dublin 8
Lappeenranta 8
Warsaw 8
Frankfurt am Main 7
Lomé 7
McKinney 7
Naples 7
Redondo Beach 7
Brooklyn 6
Chirignago 6
Farnborough 6
Jakarta 6
Johannesburg 6
Modena 6
North Hollywood 6
Nuremberg 6
Bologna 5
Cleveland 5
Poplar 5
Roncà 5
Vienna 5
Abuja 4
Baghdad 4
Carrboro 4
Chennai 4
Da Nang 4
Guatemala City 4
Houston 4
Mexico City 4
Miami 4
Philadelphia 4
Sommacampagna 4
Stockholm 4
Ankara 3
Annandale 3
Birmingham 3
Boardman 3
Boston 3
Denver 3
Des Moines 3
Genoa 3
Haiphong 3
Kyiv 3
Markham 3
Paris 3
Popayán 3
Rio de Janeiro 3
Roverbella 3
San Benedetto del Tronto 3
Seattle 3
Springfield 3
Thái Bình 3
Treviso 3
Vicenza 3
Washington 3
Allen 2
Atlanta 2
Azzano San Paolo 2
Bari 2
Barnet 2
Belo Horizonte 2
Bengaluru 2
Brasília 2
Bình Dương 2
Can Tho 2
Canelinha 2
Castelfranco Veneto 2
Totale 1.492
Nome #
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 179
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 170
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 169
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 168
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 165
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 164
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 148
Identifying Biomarkers for Remyelination and Recovery in Multiple Sclerosis: A Measure of Progress 144
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 144
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 142
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 131
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 127
Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease 119
Sleep-related hypermotor epilepsy in a patient with myelin-oligodendrocyte-glycoprotein antibody disease 114
Factors influencing longitudinal MRI structural and cognitive measures in MOGAD and MS 100
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated Disease 97
Predictors of relapse and disability in NMOSD, MOGAD, and double-seronegative demyelinating syndromes: an international multicenter retrospective cohort study 81
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 57
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis 57
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 49
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 46
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis 41
Paramagnetic Rim Lesions and Choroid Plexus Volume at Diagnosis Are Associated With Cognitive Progression Independent of Relapse and MRI Activity in Early Relapsing-Remitting Multiple Sclerosis 34
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes 33
Failed, Inconclusive or Interrupted Trials in Multiple Sclerosis: 2020-2024 Update 23
Investigating the Presence of Neurodegeneration Independent of Relapses in MOGAD Compared to Relapsing-Remitting Multiple Sclerosis 15
Totale 2.717
Categoria #
all - tutte 10.343
article - articoli 8.772
book - libri 0
conference - conferenze 1.571
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 0 0 0 6 1 1
2022/202327 1 3 1 5 1 6 0 1 2 0 6 1
2023/202469 1 3 3 6 7 11 14 2 2 6 10 4
2024/2025464 8 24 20 72 9 13 23 28 64 56 51 96
2025/20261.737 74 86 81 306 434 77 175 100 149 111 68 76
2026/2027412 56 45 81 206 24 0 0 0 0 0 0 0
Totale 2.717